Nitromint (Glyceryl Trinitrate)

Glyceryl trinitrate is converted in the body to nitric oxide, a potent vasodilator. Nitric oxide activates guanylate cyclase, raising cyclic GMP levels, which relaxes smooth muscle in veins and arteries. This vasodilation lowers cardiac preload and afterload, decreasing myocardial oxygen demand and alleviating ischemic pain.

The appropriate dose of Nitromint is determined by the prescribing clinician based on the individual patient's condition, response, and tolerance. Dosage may be adjusted over time, and patients should follow the specific instructions provided by their healthcare professional.

Safety data for glyceryl trinitrate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider after careful assessment.

To request Nitromint, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nitromint (glyceryl trinitrate) belongs to the organic nitrate class, offering rapid onset of action for acute angina relief. Compared with beta‑blockers or calcium‑channel blockers, nitrates act primarily through vasodilation rather than heart‑rate reduction, making them useful for immediate symptom control and as adjunct therapy.

Nitromint should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and sources of heat. Ensure the container is tightly closed to maintain stability and potency.

Nitromint is taken orally as directed by a physician. The tablet is swallowed whole with water, typically on an as‑needed basis for angina attacks or as part of a scheduled regimen for chronic conditions. Patients should not crush, chew, or dissolve the tablet unless specifically instructed.

The most serious risks include severe hypotension, syncope (fainting), and rare allergic reactions that may present as rash, swelling, or anaphylaxis. Prompt medical attention is required if any of these symptoms occur, especially after dose adjustments or when combined with other vasodilators.

Nitromint is contraindicated in patients with known hypersensitivity to glyceryl trinitrate or other organic nitrates, those who have taken phosphodiesterase‑5 inhibitors within the past 24–48 hours, and individuals with severe anemia or uncontrolled hypotension. Clinicians should evaluate each patient’s medical history before prescribing.